Martinus M van Veen1,2, Joana Tavares-Brito1, Britt M van Veen3, Joseph R Dusseldorp1,4, Paul M N Werker2, Pieter U Dijkstra5,6, Tessa A Hadlock1. 1. Facial Nerve Center, Department of Otolaryngology, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston. 2. Department of Plastic Surgery, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands. 3. Department of Economics, Econometrics and Finance, University of Groningen, Groningen, the Netherlands. 4. Department of Plastic and Reconstructive Surgery, Royal Australasian College of Surgeons, University of Sydney, Sydney, Australia. 5. Department of Rehabilitation Medicine, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands. 6. Department of Oral and Maxillofacial Surgery, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
Abstract
IMPORTANCE: Study of the association of regional facial dysfunction with quality of life will lead to a better understanding of quality of life in facial palsy. OBJECTIVE: To determine the association of regional facial dysfunction with facial palsy-related quality of life. DESIGN, SETTING, AND PARTICIPANTS: This retrospective cohort analysis included patients with flaccid and nonflaccid (synkinetic) facial palsy treated at a tertiary care facial nerve center; the flaccid facial palsy group included 529 patients, and the nonflaccid facial palsy group included 391 patients. Data were included from all patients with facial palsy who had an eFACE score and Facial Clinimetric Evaluation (FaCE) scale total score acquired at the same time from February 1, 2014, through October 31, 2017. Linear regression analysis was performed to calculate the amount of variance in quality of life explained by the severity of facial palsy (eFACE). A relative weight analysis was performed for the contribution of each individual eFACE item in estimating quality of life. MAIN OUTCOMES AND MEASURES: Facial palsy severity was measured using all 15 individual eFACE items (rated on a scale of 0 to 200, where 0 represents complete flaccidity, 100 represents a balanced aesthetic appearance, and 200 represents the worst imaginable hypertonia of a patient with synkinesis, with a transformation used for values from 101 to 200), and facial palsy-related quality of life was measured using the FaCE scale total score (range, 0 [worst] to 100 [best]). RESULTS: Data of 920 individual patients (59.5% female; mean [SD] age, 48.6 [16.6] years) were available. The eFACE composite score accounted for 21.2% of the quality-of-life variance in the flaccid group and 13.9% in the nonflaccid group. With the use of all 15 individual eFACE items, these proportions increased to 29.7% and 16.8%, respectively. In both groups, oral commissure movement with smile was found to be the most important contributing item (relative weight, 0.108 [95% CI, 0.075-0.148] for the flaccid group and 0.025 [95% CI, 0.005-0.052] for the nonflaccid group). Items related to the function of periocular muscles were found to be of low importance. CONCLUSIONS AND RELEVANCE: The present study suggests that the function of individual facial regions is not equally important for estimating facial palsy-related quality of life. The ability to smile is of greatest importance among patients with flaccid and nonflaccid facial palsy. The true importance of periocular function in the estimation of quality of life should be studied further in future research. LEVEL OF EVIDENCE: NA.
IMPORTANCE: Study of the association of regional facial dysfunction with quality of life will lead to a better understanding of quality of life in facial palsy. OBJECTIVE: To determine the association of regional facial dysfunction with facial palsy-related quality of life. DESIGN, SETTING, AND PARTICIPANTS: This retrospective cohort analysis included patients with flaccid and nonflaccid (synkinetic) facial palsy treated at a tertiary care facial nerve center; the flaccid facial palsy group included 529 patients, and the nonflaccid facial palsy group included 391 patients. Data were included from all patients with facial palsy who had an eFACE score and Facial Clinimetric Evaluation (FaCE) scale total score acquired at the same time from February 1, 2014, through October 31, 2017. Linear regression analysis was performed to calculate the amount of variance in quality of life explained by the severity of facial palsy (eFACE). A relative weight analysis was performed for the contribution of each individual eFACE item in estimating quality of life. MAIN OUTCOMES AND MEASURES: Facial palsy severity was measured using all 15 individual eFACE items (rated on a scale of 0 to 200, where 0 represents complete flaccidity, 100 represents a balanced aesthetic appearance, and 200 represents the worst imaginable hypertonia of a patient with synkinesis, with a transformation used for values from 101 to 200), and facial palsy-related quality of life was measured using the FaCE scale total score (range, 0 [worst] to 100 [best]). RESULTS: Data of 920 individual patients (59.5% female; mean [SD] age, 48.6 [16.6] years) were available. The eFACE composite score accounted for 21.2% of the quality-of-life variance in the flaccid group and 13.9% in the nonflaccid group. With the use of all 15 individual eFACE items, these proportions increased to 29.7% and 16.8%, respectively. In both groups, oral commissure movement with smile was found to be the most important contributing item (relative weight, 0.108 [95% CI, 0.075-0.148] for the flaccid group and 0.025 [95% CI, 0.005-0.052] for the nonflaccid group). Items related to the function of periocular muscles were found to be of low importance. CONCLUSIONS AND RELEVANCE: The present study suggests that the function of individual facial regions is not equally important for estimating facial palsy-related quality of life. The ability to smile is of greatest importance among patients with flaccid and nonflaccid facial palsy. The true importance of periocular function in the estimation of quality of life should be studied further in future research. LEVEL OF EVIDENCE: NA.
Authors: Robert A Gaudin; Mara Robinson; Caroline A Banks; Jennifer Baiungo; Nate Jowett; Tessa A Hadlock Journal: JAMA Facial Plast Surg Date: 2016-07-01 Impact factor: 4.611
Authors: Luis Lassaletta; Carolina Alfonso; Laura Del Rio; Jose Maria Roda; Javier Gavilan Journal: Ann Otol Rhinol Laryngol Date: 2006-09 Impact factor: 1.547
Authors: Matthew Ka Ki Li; Navin Niles; Sinclair Gore; Ardalan Ebrahimi; John McGuinness; Jonathan Robert Clark Journal: Head Neck Date: 2016-05-26 Impact factor: 3.147
Authors: Tessa E Bruins; Martinus M van Veen; Tanja Mooibroek-Leeuwerke; Paul M N Werker; Dieuwke C Broekstra; Pieter U Dijkstra Journal: JAMA Otolaryngol Head Neck Surg Date: 2020-04-01 Impact factor: 6.223